Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer-Reference-Cited by-同舟云学术

Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer

Published:2023-03 Issue: Volume: Page:
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:en
Short-container-title:Bulletin du Cancer

Author:

Harter Philipp,Bogner Gerhard,Chiva Luis,Cibula David,Concin Nicole,Fotopoulou Christina,Gonzalez-Martin Antonio,Guyon Frederic,Heinzelmann-Schwarz Viola,Kridelka Frederic,Mahner Sven,Marmé Frederik,Marth Christian,Morice Philippe,Novák Zoltán,Papadia Andrea,Ray-Coquard Isabelle,Redecha Mikuláš,Redondo Andres,Schwameis Richard,Sehouli Jalid,Undurraga Manuela,Van Gorp Toon,Vergote Ignace

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference42 articles.

1. Combined treatment with surgery and intraperitoneal hyperthermic perfusion (IPHP) for far-advanced gastrointestinal cancer with peritoneal seeding;Fujimoto;Acta Med Austriaca,1989

2. Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT;Möbus;J Clin Oncol,2007

3. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease;Colombo;Int J Gynecol Cancer,2019

4. Intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N Engl J Med,2006

5. Intraperitoneal chemotherapy in ovarian cancer remains experimental;Gore;J Clin Oncol,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations;JAMA Network Open;2024-04-09

2. Standardizing Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer Treatment: Navigating Complexities and Charting the Path Forward;Cancers;2024-01-17

3. Ovarian carcinoma patients with a tumorBRCA-like genomic copy number aberration profile benefit from maintenance olaparib/bevacizumab therapy in the PAOLA-1 randomized controlled trial;2023-06-01